Skip to content

Quanterix Corporation QTRX Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

Revvity logo
RevvityRVTY
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$36.4M+20.1%
Gross profit$15.6M+4.9%
Operating income-$41.4M-56.9%
Net income-$17.5M+14.5%
EPS (diluted)-$0.37+30.2%

Balance sheet

See full
Cash & equivalents$36.2M-52.7%
Total debt$35.3M-2.9%
Total equity$282.1M-10.8%
Total assets$366.7M-7.5%

Cash flow

See full
Operating cash flow-$18.1M-30.4%
CapEx$87.0K-93.1%
Free cash flow-$18.2M-20.1%

Valuation

See full
Market cap$203.97M-20.1%
Enterprise value$203.12M+28.6%
P/S1.4×-0.6×

Profitability

See full
Gross margin44.2%-14.3pp
Operating margin-96.9%-1,691pp
Net margin-71.9%-2,019pp
FCF margin-57.2%-220pp

Returns & leverage

See full
Return on equity-34.8%-122pp
Debt / equity0.1×0.0×
Current ratio3.7×-4.6×

Where this comes from

Reported directly by Quanterix Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: Quanterix Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quanterix Corporation's accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quanterix Corporation's accrued expenses and other liabilities?
Quanterix Corporation (QTRX) reported accrued expenses and other liabilities of -$7.25M in Q1 2026.
How has Quanterix Corporation's accrued expenses and other liabilities changed year-over-year?
Quanterix Corporation's accrued expenses and other liabilities decreased by 106.3% year-over-year, from -$3.52M to -$7.25M.